Cholesterol

But some industry experts said it would be impractical to do so.

"The label would be as long as your arm," said Daniel Fabricant, vice president of scientific and regulatory affairs for the Natural Products Association in Washington, D.C.

According to Carl Nielsen, who directed the FDA's import inspection programs from 1999 to 2005, it is going to take more than changing labels or adding more inspectors to ensure the safety of food imports.

The entire system needs an overhaul, he said.

"It's not a matter of throwing more resources at the current system," Nielsen said.

"The system has to be fixed." » email this page technorati Post new comment Your name: E-mail: The content of this field is kept private and will not be shown publicly.

Homepage: Subject: Comment:* Formatting guidelines: Allowed HTML tags: Lines and paragraphs break automatically.

More information about formatting options Recent Stories Raiders get Russell, not much else: Other draft viewsParties made easy, from Cinco de Mayo to graduationCard company raises rate over debt ratioWith a flood of imports, food safety is in doubtIn th...

Cincinnati.Com » The Enquirer » Business » KFC goes trans-fat free LOCAL BUSINESS Pizza Hut rolls out hand-tossed pizza -> Untitled Quick Links Cincinnati.Com Business Tip Sheet .investchart{font-family: arial,helvetica,verdana,sans-serif;font-size: 12px;color: #000;} Investor Center As of 12:59 PM EST IndexLastChange Mutual Funds Enter symbol orcompan...

"It has the potential of becoming a new drug for the treatment of human genetic disease." The findings described in this article significantly raise the possibility that new therapies could arise where defective DNA is deactivated more completely and more thoroughly than ever before.

For instance, Zorro-LNA could be used in combination with "RNA interference" (RNAi).

Like Zorro-LNA, RNAi has the ability to deactivate genes, but does so by degrading the gene’s RNA.

In addition, Zorro-LNA could be used to deactivate certain genes in stem cells, which could eventually lead to the development of new cells, tissues, or organs.

The discovery of RNAi was recognized by a Nobel Prize award in 2006 to two American scientists.

"This is a major development in the treatment not only of genetic diseases, but also of acquired diseases when microbes or toxins cause genes to go awry" said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal.

"One might say these researchers have found a gene-hunter’s Holy Grail for which scientists have been hunting for many years.

Zorro-LNA should give us a new, safe way of blocking the effects of errors in our genetic repertoire." Source: Federation of American Societies for Experimental B...